← Back to Search
Radiation Dose-volume Effects In The Lung.
L. Marks, S. Bentzen, J. Deasy, F. Kong, J. Bradley, I. S. Vogelius, I. El Naqa, J. Hubbs, J. Lebesque, R. Timmerman, M. Martel, A. Jackson
Published 2010 · Medicine
Download PDFAnalyze on Scholarcy
The three-dimensional dose, volume, and outcome data for lung are reviewed in detail. The rate of symptomatic pneumonitis is related to many dosimetric parameters, and there are no evident threshold "tolerance dose-volume" levels. There are strong volume and fractionation effects.
This paper references
Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models
L. Marks (2008)
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
Y. Seppenwoolde (2003)
Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
S. Tucker (2006)
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
S. Wang (2006)
Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis.
S. L. Kwa (1998)
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer
R. Timmerman (2007)
Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.
Y. Seppenwoolde (2004)
Radiation-induced lung injury.
L. Marks (2003)
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.
R. Timmerman (2003)
Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis.
F. Kong (2005)
Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
K. L. Miller (2005)
Elective whole lung irradiation in the treatment of osteogenic sarcoma
G. Rab (1976)
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
E. Yorke (2005)
Systemic (half-body) radiation therapy: response and toxicity.
O. Salazar (1978)
Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung.
J. Van Dyk (1981)
Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
A. Hope (2006)
Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.
D. Antonadou (2003)
Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
M. Ozsahin (1996)
Challenges in defining radiation pneumonitis in patients with lung cancer.
Z. Koçak (2005)
Dose response and factors related to interstitial pneumonitis after bone marrow transplant.
Sagus Sampath (2005)
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
J. Bradley (2007)
Radiation pneumonitis: experience following a large single dose of radiation.
C. Fryer (1978)
Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.
J. Schallenkamp (2007)
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
D. Oetzel (1995)
The role of lung perfusion imaging in predicting the direction of radiation‐induced changes in pulmonary function tests
L. Marks (2000)
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
T. Rancati (2003)
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
D. Rice (2007)
Normal Tissue Complication Probability
Ioannis Grout (2011)
A Little to a Lot or a Lot to a Little?
J. Willner (2003)
Irradiation of the lungs as an adjuvant therapy in the treatment of osteosarcoma of the limbs. An E.O.R.T.C. randomized study.
K. Breur (1978)
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer
R. Timmerman (2006)
Osteosarcoma of the limbs. Report of the EORTC‐SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation
J. M. V. Burgers (1988)
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
T. Kim (2005)
The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy.
T. Wheldon (1998)
Loco-regional differences in pulmonary function and density after partial rat lung irradiation.
E. M. Wiegman (2003)
Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
E. Miles (2008)
Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
H. Onishi (2003)
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
B. Movsas (2005)
Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer.
D. Antonadou (2001)
Pulmonary toxicity of chemotherapy.
M. Meadors (2006)
Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial.
B. Ozturk (2004)
Radiobiological modeling for treatment planning
V Moiseenko (2005)
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.
T. J. Robnett (2000)
Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
H. Yamashita (2007)
Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis
Y. Seppenwoolde (2003)
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.
M. Roach (1995)
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.
M. Martel (1994)
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
F. Kong (2006)
Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer.
J. Armstrong (1995)
The Modern Technology of Radiation Oncology: A Compendium for Medical Physicists and Radiation Oncologists
J. V. Dyk (1999)
Radiation damage to the heart enhances early radiation-induced lung function loss.
P. van Luijk (2005)
Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
K. Tsujino (2006)
The simultaneous boost technique: the concept of relative normalized total dose.
J. Lebesque (1991)
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
M. Graham (1999)
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Sonal Sura (2008)
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.
K. Tsujino (2003)
Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors.
R. Hara (2004)
Total thoracic irradiation combined with intravenous injection of autogenous marrow.
K. Newton (1960)
Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta.
X. Fu (2001)
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy.
G. Bacci (2002)
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
E. Yorke (2002)
An analysis of 40 cases treated by total thoracic irradiation.
K. Newton (1969)
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
V. Mehta (2005)
Pulmonary radiation injury.
B. Movsas (1997)
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
R. Komaki (2004)
Pulmonary radiation injury: identification of risk factors associated with regional hypersensitivity.
Alena Novakova-Jiresova (2005)
Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
S. Yom (2007)
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.
M. L. Hernando (2001)
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.
S. L. Kwa (1998)
Quantitative clinical radiobiology of early and late lung reactions.
S. Bentzen (2000)
This paper is referenced by
Utilizing Computed Tomography Image Features to Advance Prediction of Radiation Pneumonitis
S. Krafft (2016)
Inclusion of dosimetric data as covariates in toxicity-related radiogenomic studies
N. Yahya (2018)
Accuracy and Uncertainty Considerations in Modern Radiation Oncology
J. V. Dyk (2013)
Validating PET segmentation of thoracic lesions-is 4D PET necessary?
M. S. Nielsen (2017)
The dependence of optimal fractionation schemes on the spatial dose distribution.
J. Unkelbach (2013)
Clinical controversies: proton therapy for thoracic tumors.
D. D. De Ruysscher (2013)
Symptomatic radiation pneumonitis in elderly patients receiving thoracic irradiation.
J. Kharofa (2013)
Comparison of biologically effective dose for treatment planning in the fixed-beam intensity-modulated radiotherapy and the volumetric-modulated arc therapy for the typical types of cancer
S. Wang (2019)
Prognostic biological factors of radiation pneumonitis after stereotactic body radiation therapy combined with pulmonary perfusion imaging.
L. Guo (2019)
Towards the treatment of moving targets with scanned proton beams
Andreas SchÃ¤tti (2013)
Personalized Management of Lung Cancer
Ritsuko Komaki (2013)
A portable fast neutron irradiation system for tumor therapy.
Shiwei Jing (2020)
Dosimetric evaluation of incidental irradiation to the axilla during whole breast radiotherapy for patients with left-sided early breast cancer in the IMRT era
Jayoung Lee (2016)
Nondosimetric risk factors for radiation-induced lung toxicity.
F. Kong (2015)
Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort
S. Tucker (2014)
A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making.
C. Oberije (2014)
Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.
D. Owen (2018)
Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imaging
M. Matuszak (2016)
Self‐expanding stent effects on radiation dosimetry in esophageal cancer
Samual R. Francis (2013)
Method of predicting the mean lung dose based on a patient׳s anatomy and dose-volume histograms.
A. Zawadzka (2017)
Development and validation of a decision support tool to select IMRT as radiotherapy treatment planning modality for patients with locoregionally advanced non-small cell lung cancers (NSCLC).
R. Shrimali (2019)
RadioBio data: A Moddicom Module to Predict Tumor Control Probability and Normal Tissue Complication Probability in Radiotherapy
N. Dinapoli (2016)
Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
J. Kharofa (2012)
Aalborg Universitet Validating PET segmentation of thoracic lesions-is 4 D PET necessary ?
Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective
M. Cremonesi (2014)
Radiobiological rationale for stereotactic hypofractionated radiosurgery Part II. Normal tissue tolerance — dose constraints
B. Maciejewski (2018)
ASSESSMENT OF UNCERTAINTY IN PLANNING AND DOSE DELIVERY OF PROTON THERAPY IN AN IROC- HOUSTON QA PHANTOM DUE TO VARIABLE CT TECHNIQUE AND PROTON ENERGY
Mattie M McInnis (2015)
Radiotherapeutic implications of the updated ICRP thresholds for tissue reactions related to cataracts and circulatory diseases
L. Dauer (2018)
Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues
H. Yu (2018)
Advantages of CyberKnife for inoperable stage I peripheral non-small-cell lung cancer compared to three-dimensional conformal radiotherapy.
An-Na Tong (2015)
Investigation of Association Between Cardiac Dose Distribution and Strain/Tissue Doppler Echocardiographic Indices During 1-Year Post-Mastectomy Radiation Therapy Follow-Up in Breast Cancer Patients
Soodabeh Shahidsales (2020)
A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer
P. M. Rosenschöld (2010)See more